Mar 21, 2016
A positive editorial discussion on LTX-315`s mode of action in the journal Cell Cycle

Positive editorial discussion in the Journal: Cell Cycle, focusing on LTX-315 as a cationic anticancer peptide (CAP)  which is “CAPtivating immunity with necrosis”.

Read article